Personalized Medicine Market Analysis
06-Aug-2011 | News-Press Release
With the expansion of our knowledge of genetics and molecular biology, personalized approach to medical care is increasingly becoming important. While still in the early stages, personalized medicine is steadily emerging as the new healthcare paradigm. In fact, this paradigm not only promises the improvement of an individual’s treatment outcome and reduces healthcare expenditure; but is set to transform the biopharmaceutical and molecular diagnostics markets in the coming years.
According to our new research report “Personalized Medicine Market Analysis”, the U.S. market for personalized medicine is anticipated to grow at a CAGR of around 12% during 2009-2015. Growth will be driven by factors, such as treatment costs savings, early detection of diseases, patient compliance, drug safety, and optimization of therapies.
Presently, the industry as a whole is committed to the development of personalized medicines and is commanding more resources and fomenting more corresponding organization change. In fact, strategic alliances, like the Sanofi-Aventis alliance with Scripps Genomic Medicine, are being formed with academic and private research institutions as well as small biotech companies and major pharma companies are increasingly looking for alternative ways to strengthen their pipelines.
Our report has found that the market is presently dominated by Oncology applications. However, therapeutic applications of personalized medicines will extend to new therapy areas in the coming years. Further, the US, Europe, China, and Japan are the major geographical markets exhibiting healthy growth rates.
The report provides extensive information and rational analysis of the global personalized medicine market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. The report also provides an insight into the segment-wise market trends prevailing at the regional level to present an overview of the developments taking place in these segments across the world.
For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=177549&rt=Personalized-Medicine-Market-Analysis.html
Related Reports
Medicines Co.-Deals & Alliances Report
http://www.bharatbook.com/detail.asp?id=136777&rt=Medicines-Co-Deals-Alliances-Report.html
China Medicine Corporation-Detailed Product Pipeline
http://www.bharatbook.com/detail.asp?id=137752&rt=China-Medicine-Corporation-Detailed-Product-Pipeline.html
-30-
Or
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/BharatBook
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
- The Geothermal Energy Market 2012-2022
- Adhesives and Sealants: Global Markets
- Dermatological Drugs: World Market Prospects 2012-2022
- The Electric and Range Extended Electric Light-Vehicle Report
- India Urban & Industrial Waste to Energy Market
- Understanding Russia's Regional Health Markets
- 2012 Deep Research Report on China Wind Bearing Industry
- Top 1000 Advertising Agents (European)
- HNWI Asset Allocation in Switzerland to 2016